Sat, Jul 26, 2014, 4:49 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Johnson & Johnson Message Board

  • adspatz adspatz Jul 16, 2013 11:18 AM Flag

    Johnson & Johnson reports second quarter profit increases

    Search for "SEC Live Filings Digest" to find out more.
    Johnson & Johnson (JNJ) announced its financial results for second quarter fiscal 2013, reporting $17.9B in earnings, up from $16.5B the same quarter last year. The $17.9B in earnings and $1.48 earnings per share beat analyst expectations of $17.7B and earnings per share of $1.39. The company has raised its annual guidance from $5.35 to $5.45 per share up to $5.40 to $5.47 per share. The sale of its share in Elan for $1.26B distorted the financial results in a positive way but regardless of the sale, the increase in its guidance has all analysts optimistic. J&J attributes a lot of its success this quarter to the increased demand of its newer pharmaceutical products including Zytiga, a prostate cancer medicine, and Xarelto, a blood thinner.

102.11-0.09(-0.09%)Jul 25 4:01 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.